Vertex Pharmaceuticals: 4th week of a buy, up 7.5%
Vertex Pharmaceuticals flat at +0.1%: the buy signal cools at the double bottom
Vertex Pharmaceuticals: 4th week of a buy, up 7.5%
Our view last week
Vertex Pharmaceuticals shares gave back 8.1% this week, after last week's 16.9% surge that already hit the first of the 3 targets of our most advanced model. Price touched a double bottom in the 427 area and bounced 8% off it, but sellers ruled the last session's trade: the bounce isn't confirmed by volume yet. The trade is still up 7.5%.
This week's summary
Vertex Pharmaceuticals closed the week almost flat (+0.1%), after last week's -8.1% giveback: price carved a fresh double bottom in the 434 area, with a 4% intermediate rebound, but sellers still rule the tape — barely a quarter of the volume is on the buy side. The buy signal, now in its fourth week, is showing the first signs of fading: strength drops to 66 out of 100. The trade is still up 7.5%, with earnings 2 weeks away adding a note of caution.
IQS Phase
56
ordinary
Signal Strength
66
medium
Sizing
STANDARD
Ranking
#27 / 112
US stocks in progress
Trade P&L %
+7.53%
from signal to today
restricted Platinum content